Roper Technologies analysis: capital-light vertical market software compounder, 2025 growth outlook, valuation at 19x FCF, ...
Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback